STAGE IIB PROSTATE CANCER
Clinical trials for STAGE IIB PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two radiation methods join forces against prostate cancer
Disease control OngoingThis early-phase trial tests the safety of combining two types of radiation for men with intermediate-risk prostate cancer. First, a small radioactive source is placed inside the prostate for 10-20 minutes (high dose rate brachytherapy), followed by three weeks of highly targeted…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New radiation approach aims to tame prostate cancer with fewer side effects
Disease control OngoingThis study tests a type of radiation called high-dose brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to deliver a strong dose to the tumor while sparing nearby healthy tissue. The goal is to control…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 01, 2026 18:05 UTC
-
New radiation approach aims to zap prostate cancer with fewer side effects
Symptom relief OngoingThis study tests a precise type of radiation (stereotactic body radiation therapy) for men whose prostate cancer has returned after surgery. The goal is to find the safest and most effective dose while limiting damage to healthy tissue. 26 men with recurrent prostate cancer will …
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 17, 2026 03:14 UTC